SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 28.30-7.7%Nov 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (411)1/13/2009 6:38:01 PM
From: mcbio  Read Replies (1) of 566
 
Thanks for the timely and helpful reply Tuck. That alleviates any near-term concerns for me.

RIGL has said they expect to have a partner for R788 by the end of 1Q 09. Any idea who it might be or potential terms? I would think that Pfizer would make sense, since they're already partnered with RIGL for R343, another Syk inhibitor, for asthma. Also, Pfizer has their own oral RA candidate, so a partnership for R788 could make them a dominant player in this space.

And welcome back aboard! I just added to my position and plan to add more in the near future. I like the risk/reward here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News